Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Conjugate vaccines].

B Swennen1, J Sternon

  • 1Unité d'Epidémiologie pédiatrique et Vaccination, Ecole de Santé publique, U.L.B.

Revue Medicale De Bruxelles
|November 9, 2002
PubMed
Summary
This summary is machine-generated.

Conjugate vaccines provide crucial protection for young children against serious infections like Haemophilus influenzae type b, meningococcal C, and pneumococcal disease by enhancing immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High number of hospitalisations and non-classical presentations: lessons learned from a measles outbreak in 2017, Belgium.

Epidemiology and infection·2020
Same author

Traitement Des Infections Bronchopulmonaires Aigues Par Le Laurylsulfate De Tetracycline Intra-Musculaire.

Acta clinica Belgica·2016
Same author

[Determinants of breastfeeding in the Brussels Region].

Revue medicale de Bruxelles·2015
Same author

Breastfeeding duration: a survival analysis-data from a regional immunization survey.

BioMed research international·2014
Same author

[Breastfeeding in the French-speaking community of Belgium (2009)].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2014
Same author

[Vaccination: cost-effectiveness ratio].

Revue medicale de Bruxelles·2009
Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018
Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018
Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018
Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018
Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018
See all related articles

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Immunology

Background:

  • Conjugate vaccines are essential for extending vaccinal prevention in children.
  • They convert T-independent antigens into T-dependent ones by linking capsular polysaccharides to carrier proteins.
  • This mechanism enables protection in children under two years of age.

Purpose of the Study:

  • To review three key conjugate vaccines and their clinical outcomes.
  • To address critical questions regarding antigen interference, serological surrogates for protection, herd immunity, and serotype replacement.

Main Methods:

  • Review of existing literature and clinical data on conjugate vaccines.
  • Analysis of immunological responses, focusing on antigen interference.

Related Experiment Videos

  • Evaluation of serological markers and epidemiological data related to herd immunity and serotype dynamics.

    • Main Results:

    • Conjugate vaccines significantly improve protection against targeted pathogens in young children.
    • Antigen interference can modulate the immune response, requiring careful vaccine formulation.
    • Evidence supports the role of serological surrogates in predicting vaccine efficacy.
    • Herd immunity effects are observed, alongside concerns about the replacement of circulating serotypes.

    Conclusions:

    • Conjugate vaccines represent a major advancement in pediatric infectious disease prevention.
    • Further research is needed to fully understand and mitigate antigen interference and serotype replacement.
    • Optimizing vaccine strategies requires ongoing monitoring of immunological responses and epidemiological trends.